| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Milica Pjevac, Liam Korošec Hudni. A case report-"When less is more": controlled inpatient reduction of anticholinergic burden in a patient with clozapine-resistant schizophrenia. Frontiers in psychiatry. vol 14. 2023-08-16. PMID:37583839. |
the relationship between clozapine treatment and cognitive impairment in individuals with schizophrenia is an intricate one. |
2023-08-16 |
2023-09-07 |
Not clear |
| Yiying Hu, Xiaopei Xu, Liyuan Luo, Huichao Li, Wangtao Li, Liyuan Guo, Lanying Li. Different degrees of nodes behind obsessive-compulsive symptoms of schizophrenia. Frontiers in psychiatry. vol 14. 2023-08-14. PMID:37575581. |
in this study, we aimed to investigate the mechanism of schizophrenia with obsessive-compulsive symptoms by using diffusion tensor imaging (dti)-based structural brain connectivity analysis to assess the network differences between patients with obsessive-compulsive disorder (ocd), patients with schizophrenia showing obsessive-compulsive symptoms (sch), schizophrenia patients with obsessive-compulsive symptoms due to clozapine (ldp), and healthy controls (cn). |
2023-08-14 |
2023-08-16 |
human |
| Phillipa Louise Brothwood, Mina Husain, Jessica Pinson, Ebenezer Oloyede, Patrick Davey, Eromona Whiske. Clozapine in Combination With Olanzapine Long-Acting Injection: The Intersection of Treatment-Resistant Schizophrenia and Poor Medication Adherence-A Case Report. Journal of clinical psychopharmacology. 2023-08-07. PMID:37548611. |
clozapine in combination with olanzapine long-acting injection: the intersection of treatment-resistant schizophrenia and poor medication adherence-a case report. |
2023-08-07 |
2023-08-14 |
Not clear |
| Sherry Kit Wa Chan, Yi Nam Suen, Wai Ching Yan, Chun Lam, Eileena Chui, Christy Lai Ming Hui, Wing Chung Chang, Edwin Ho Ming Lee, Eric Yu Hai Chen, William G Honer, Hiroyoshi Takeuch. Clozapine dosing patterns and clinical outcomes in patients with treatment resistant schizophrenia. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 75. 2023-08-07. PMID:37549438. |
clozapine dosing patterns and clinical outcomes in patients with treatment resistant schizophrenia. |
2023-08-07 |
2023-08-14 |
Not clear |
| Elias Wagner, Wolfgang Strube, Thomas Görlitz, Aslihan Aksar, Ingrid Bauer, Mattia Campana, Joanna Moussiopoulou, Alexander Hapfelmeier, Petra Wagner, Silvia Egert-Schwender, Robert Bittner, Kathrin Eckstein, Igor Nenadić, Tilo Kircher, Berthold Langguth, Eva Meisenzahl, Martin Lambert, Sigrid Neff, Berend Malchow, Peter Falkai, Dusan Hirjak, Kent-Tjorben Böttcher, Andreas Meyer-Lindenberg, Christiane Blankenstein, Stefan Leucht, Alkomiet Hasa. Effects of Early Clozapine Treatment on Remission Rates in Acute Schizophrenia (The EARLY Trial): Protocol of a Randomized-Controlled Multicentric Trial. Pharmacopsychiatry. 2023-07-28. PMID:37506738. |
effects of early clozapine treatment on remission rates in acute schizophrenia (the early trial): protocol of a randomized-controlled multicentric trial. |
2023-07-28 |
2023-08-14 |
Not clear |
| Francesco Monteleone, Márcia Gonçalves, Luís Fonseca, Sónia Simões, Andreia Gonçalves, Eduarda Machado, João Fonsec. Clozapine-Induced Eosinophilia: a Case Report. Revista Colombiana de psiquiatria (English ed.). vol 52. issue 2. 2023-07-27. PMID:37500239. |
clozapine is an atypical antipsychotic drug eligible for treatment-resistant schizophrenia. |
2023-07-27 |
2023-08-14 |
Not clear |
| Rowena Jones, Isabel Morales-Munoz, Adrian Shields, Graham Blackman, Sophie E Legge, Megan Pritchard, Daisy Kornblum, James H MacCabe, Rachel Upthegrov. Early neutrophil trajectory following clozapine may predict clozapine response - Results from an observational study using electronic health records. Brain, behavior, and immunity. 2023-07-26. PMID:37494985. |
clozapine has unique effectiveness in treatment-resistant schizophrenia and is known to cause immunological side-effects. |
2023-07-26 |
2023-08-14 |
Not clear |
| Dhandapani Nandakumar, Ragul Ganesh, Koushik S Deb, Raka Jain, Mamta Soo. Disability and quality of life in patients with treatment-resistant schizophrenia on long- term clozapine therapy. Indian journal of psychiatry. vol 65. issue 6. 2023-07-24. PMID:37485411. |
disability and quality of life in patients with treatment-resistant schizophrenia on long- term clozapine therapy. |
2023-07-24 |
2023-08-14 |
Not clear |
| Dhandapani Nandakumar, Ragul Ganesh, Koushik S Deb, Raka Jain, Mamta Soo. Disability and quality of life in patients with treatment-resistant schizophrenia on long- term clozapine therapy. Indian journal of psychiatry. vol 65. issue 6. 2023-07-24. PMID:37485411. |
to assess disability and quality of life (qol) in treatment resistant schizophrenia (trs) on long term clozapine therapy and assess their correlation with positive, negative and cognitive symptoms. |
2023-07-24 |
2023-08-14 |
Not clear |
| Wen-Yin Chen, Pao-Huan Chen, Chun-Hung Pan, Sheng-Siang Su, Shang-Ying Tsai, Chiao-Chicy Chen, Chian-Jue Ku. Clozapine and its protective effect on all-cause, natural, and suicide mortality in patients with schizophrenia: A nationwide cohort study in Taiwan. Schizophrenia research. 2023-07-21. PMID:37479588. |
clozapine and its protective effect on all-cause, natural, and suicide mortality in patients with schizophrenia: a nationwide cohort study in taiwan. |
2023-07-21 |
2023-08-14 |
Not clear |
| Wen-Yin Chen, Pao-Huan Chen, Chun-Hung Pan, Sheng-Siang Su, Shang-Ying Tsai, Chiao-Chicy Chen, Chian-Jue Ku. Clozapine and its protective effect on all-cause, natural, and suicide mortality in patients with schizophrenia: A nationwide cohort study in Taiwan. Schizophrenia research. 2023-07-21. PMID:37479588. |
clozapine is indicated as the last-line agent for the treatment of refractory schizophrenia due to its side effects. |
2023-07-21 |
2023-08-14 |
Not clear |
| Wen-Yin Chen, Pao-Huan Chen, Chun-Hung Pan, Sheng-Siang Su, Shang-Ying Tsai, Chiao-Chicy Chen, Chian-Jue Ku. Clozapine and its protective effect on all-cause, natural, and suicide mortality in patients with schizophrenia: A nationwide cohort study in Taiwan. Schizophrenia research. 2023-07-21. PMID:37479588. |
this study included an asian schizophrenia population and investigated the effect of clozapine on the risks of all-cause, natural, and suicide mortality. |
2023-07-21 |
2023-08-14 |
Not clear |
| Joshep Revilla-Zúñiga, Joise Cornejo-Del Carpio, Lizardo Cruzad. Hepatoxicity induced by clozapine: Case report and brief review. Revista Colombiana de psiquiatria (English ed.). 2023-07-17. PMID:37460343. |
clozapine is an atypical antipsychotic used in treatment-resistant schizophrenia and there is evidence that it can produce elevations of hepatic transaminases, expression of liver damage in a hepatocellular pattern. |
2023-07-17 |
2023-08-14 |
Not clear |
| Drozdstoy Stoyano. Commentary: "Exploring the "Insight Paradox" in Treatment Resistant Schizophrenia: Correlations Between Dimensions of Insight and Depressive Symptoms in Patients Receiving Clozapine". Alpha psychiatry. vol 24. issue 3. 2023-07-13. PMID:37440896. |
commentary: "exploring the "insight paradox" in treatment resistant schizophrenia: correlations between dimensions of insight and depressive symptoms in patients receiving clozapine". |
2023-07-13 |
2023-08-14 |
Not clear |
| Süleyman Dönmezler, Gizem İskender, Nurhan Fıstıkcı, Yavuz Altunkaynak, Sevinç Ulusoy, Tonguç Demir Berko. Exploring the "Insight Paradox" in Treatment-Resistant Schizophrenia: Correlations Between Dimensions of Insight and Depressive Symptoms in Patients Receiving Clozapine. Alpha psychiatry. vol 24. issue 3. 2023-07-13. PMID:37440902. |
exploring the "insight paradox" in treatment-resistant schizophrenia: correlations between dimensions of insight and depressive symptoms in patients receiving clozapine. |
2023-07-13 |
2023-08-14 |
Not clear |
| Süleyman Dönmezler, Gizem İskender, Nurhan Fıstıkcı, Yavuz Altunkaynak, Sevinç Ulusoy, Tonguç Demir Berko. Exploring the "Insight Paradox" in Treatment-Resistant Schizophrenia: Correlations Between Dimensions of Insight and Depressive Symptoms in Patients Receiving Clozapine. Alpha psychiatry. vol 24. issue 3. 2023-07-13. PMID:37440902. |
we therefore set our primary aim to evaluate relationship between insight dimensions and depressive symptoms in patients with treatment-resistant schizophrenia receiving clozapine. |
2023-07-13 |
2023-08-14 |
Not clear |
| Alessandra Manca, Jacopo Mula, Alice Palermiti, Flavio Vischia, David De Cori, Sara Venturello, Guido Emanuelli, Domenico Maiese, Miriam Antonucci, Amedeo De Nicolò, Elisa Delia De Vivo, Jessica Cusato, Antonio D'Avoli. Vitamin D impact in affecting clozapine plasma exposure: A potential contribution of seasonality. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. vol 165. 2023-07-06. PMID:37413901. |
schizophrenia affects approximately 24 million people worldwide and clozapine is the most effective antipsychotic drug. |
2023-07-06 |
2023-08-14 |
Not clear |
| Shih-Ku Lin, Hsien-Yuan Lan. A brief history of clozapine use in Taiwan. Schizophrenia research. 2023-06-30. PMID:37391310. |
in conclusion, clozapine is a widely used in patients with schizophrenia in taiwan. |
2023-06-30 |
2023-08-14 |
Not clear |
| Sandeep Grover, Chandrima Naska. Patient and caregivers perspective about clozapine: A systematic review. Schizophrenia research. 2023-06-29. PMID:37385885. |
clozapine is a gold standard treatment for treatment-resistant schizophrenia. |
2023-06-29 |
2023-08-14 |
Not clear |
| Maxine Yang, Arielle Rubin, Rebecca Wondimu, Theresa Grebe, Gaby Ritfel. Significant improvement of psychotic symptoms in treatment-resistant schizophrenia with clozapine in an adolescent with SHINE syndrome: a case report. BMC psychiatry. vol 23. issue 1. 2023-06-29. PMID:37386468. |
significant improvement of psychotic symptoms in treatment-resistant schizophrenia with clozapine in an adolescent with shine syndrome: a case report. |
2023-06-29 |
2023-08-14 |
Not clear |